Sharon Henderson

Tracking the currents of power, money, and influence in a world of change.

SH
Editor
Sharon Henderson

About This Column

Sharon Henderson is an analyst of the flows that govern our world - not just capital, but influence, innovation, and strategic leverage. Formerly the voice behind Capital Currents, Sharon has expanded her scope to examine the broader forces reshaping the global landscape. She specializes in deconstructing the "strategic rationale" behind major shifts, whether in the boardroom, the tech sector, or the geopolitical arena. Her column is a destination for those who want to understand the underlying mechanics of power and the quiet moves that will define the next decade of the global economy.

Displaying items 261-280 of 337 in total

Curogen's Dual Leap: Korean Grant Fuels Global Autoimmune Drug Push

Read full article
Curogen's Dual Leap: Korean Grant Fuels Global Autoimmune Drug Push

Varvee Global Boosts Fabric Output in Strategic Non-Denim Pivot

Read full article
BriefGlance

New Hope for FTD: $2.1M Initiative Aims to Revolutionize Diagnosis

Read full article
New Hope for FTD: $2.1M Initiative Aims to Revolutionize Diagnosis

Banijay Sells Bet-at-home to Forge New European Gaming Powerhouse

Read full article
Banijay Sells Bet-at-home to Forge New European Gaming Powerhouse

Nexxen's $40M Buyback: A Bold Confidence Signal in a Shifting Ad Tech Market

Read full article
Nexxen's $40M Buyback: A Bold Confidence Signal in a Shifting Ad Tech Market

Wesdome Taps Finance Veteran Faheem Tejani for Board Amid Growth Push

Read full article
Wesdome Taps Finance Veteran Faheem Tejani for Board Amid Growth Push

Veracyte at JPM: High Stakes for AI-Powered Cancer Diagnostics

Read full article
Veracyte at JPM: High Stakes for AI-Powered Cancer Diagnostics

Alico's New Blueprint: From Citrus Groves to Florida Real Estate

Read full article
Alico's New Blueprint: From Citrus Groves to Florida Real Estate

Greenwich Insiders Lock Shares for 6 Years on Promising Cancer Drug Data

Read full article
Greenwich Insiders Lock Shares for 6 Years on Promising Cancer Drug Data

Boxabl Secures Key California License, Paving Way for Expansion

Read full article
Boxabl Secures Key California License, Paving Way for Expansion

Claranova's $2.5M Settlement Spotlights Subscription Law Crackdown

Read full article
BriefGlance

Edible Garden & Weis Markets Forge a New Path for Sustainable Groceries

Read full article
Edible Garden & Weis Markets Forge a New Path for Sustainable Groceries

DoControl and Sentra Unite to Automate SaaS Data Security Actions

Read full article
DoControl and Sentra Unite to Automate SaaS Data Security Actions

Half of US Small Businesses Hit by Cyberattacks, Report Reveals

Read full article
BriefGlance

Hut 8's $7B AI Data Center Deal Signals Major Louisiana Tech Boom

Read full article
Hut 8's $7B AI Data Center Deal Signals Major Louisiana Tech Boom

Propel Fuses CAD Data and AI to Remake the Product Lifecycle

Read full article
Propel Fuses CAD Data and AI to Remake the Product Lifecycle

Thailand's New Playbook: Stars, Drones & A Bid for the Global Stage

Read full article
Thailand's New Playbook: Stars, Drones & A Bid for the Global Stage

Immunome’s $400M Gambit: Fueling Cancer Drugs with Shareholder Cash

Read full article
Immunome’s $400M Gambit: Fueling Cancer Drugs with Shareholder Cash

The Browser Is the New Battlefield: Seraphic Leads the Zero Trust Charge

Read full article
The Browser Is the New Battlefield: Seraphic Leads the Zero Trust Charge

Gray Media's $250M Debt Shuffle: A Bet on Growth in a High-Stakes Game

Read full article
BriefGlance
UCID: 53